The primary efficacy objective is to evaluate whether dabigatran etexilate is superior to
placebo in the long-term prevention of recurrent symptomatic venous thrombo-embolism (VTE)
in patients with symptomatic deep-vein thrombosis (DVT) or pulmonary embolism (PE) who
completed 6 to 18 months of treatment with vitamin K antagonist (VKA).
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
1160.63.43005 Boehringer Ingelheim Investigational Site, Graz, Austria
1160.63.43006 Boehringer Ingelheim Investigational Site, Innsbruck, Austria
1160.63.43001 Boehringer Ingelheim Investigational Site, Wien, Austria
1160.63.43002 Boehringer Ingelheim Investigational Site, Wien, Austria
1160.63.43004 Boehringer Ingelheim Investigational Site, Wien, Austria
1160.63.32005 Boehringer Ingelheim Investigational Site, Aalst, Belgium
1160.63.32004 Boehringer Ingelheim Investigational Site, Duffel, Belgium
1160.63.32003 Boehringer Ingelheim Investigational Site, Kortrijk, Belgium
1160.63.32001 Boehringer Ingelheim Investigational Site, Leuven, Belgium
1160.63.32002 Boehringer Ingelheim Investigational Site, Lier, Belgium
1160.63.02020 Boehringer Ingelheim Investigational Site, Quebec, Canada
1160.63.42004 Boehringer Ingelheim Investigational Site, Ceske Budejovice, Czech Republic
1160.63.42003 Boehringer Ingelheim Investigational Site, Jablonec nad Nisou, Czech Republic
1160.63.42008 Boehringer Ingelheim Investigational Site, Kladno, Czech Republic
1160.63.42012 Boehringer Ingelheim Investigational Site, Liberec, Czech Republic
1160.63.42010 Boehringer Ingelheim Investigational Site, Nymburk, Czech Republic
1160.63.42011 Boehringer Ingelheim Investigational Site, Ostrava-Vitkovice, Czech Republic
1160.63.42009 Boehringer Ingelheim Investigational Site, Ostrava, Czech Republic
1160.63.42002 Boehringer Ingelheim Investigational Site, Prague 4-Krc, Czech Republic
1160.63.42001 Boehringer Ingelheim Investigational Site, Prague 4, Czech Republic
1160.63.42006 Boehringer Ingelheim Investigational Site, Praha 4, Czech Republic
1160.63.42005 Boehringer Ingelheim Investigational Site, Prostejov, Czech Republic
1160.63.42007 Boehringer Ingelheim Investigational Site, Rakovnik, Czech Republic
1160.63.42013 Boehringer Ingelheim Investigational Site, Slany, Czech Republic
1160.63.42014 Boehringer Ingelheim Investigational Site, Tabor, Czech Republic
1160.63.37202 Boehringer Ingelheim Investigational Site, Kohtla-Järve, Estonia
1160.63.37203 Boehringer Ingelheim Investigational Site, Tallin, Estonia
1160.63.37201 Boehringer Ingelheim Investigational Site, Tartu, Estonia
1160.63.49013 Boehringer Ingelheim Investigational Site, Darmstadt, Germany
1160.63.49017 Boehringer Ingelheim Investigational Site, Dresden, Germany
1160.63.49018 Boehringer Ingelheim Investigational Site, Dresden, Germany
1160.63.49014 Boehringer Ingelheim Investigational Site, Gießen, Germany
1160.63.49011 Boehringer Ingelheim Investigational Site, Ludwigshafen, Germany
1160.63.49005 Boehringer Ingelheim Investigational Site, Mannheim, Germany
1160.63.49010 Boehringer Ingelheim Investigational Site, Mannheim, Germany
1160.63.49007 Boehringer Ingelheim Investigational Site, München, Germany
1160.63.49009 Boehringer Ingelheim Investigational Site, Püttlingen, Germany
1160.63.39006 Boehringer Ingelheim Investigational Site, Bergamo, Italy
1160.63.39015 Boehringer Ingelheim Investigational Site, Castelfranco Veneto (TV), Italy
1160.63.39019 Boehringer Ingelheim Investigational Site, Chieti Scalo (CH), Italy
1160.63.39003 Boehringer Ingelheim Investigational Site, Cosenza, Italy
1160.63.39008 Boehringer Ingelheim Investigational Site, Fidenza (PR), Italy
1160.63.39011 Boehringer Ingelheim Investigational Site, Firenze, Italy
1160.63.39009 Boehringer Ingelheim Investigational Site, Genova, Italy
1160.63.39004 Boehringer Ingelheim Investigational Site, Milano, Italy
1160.63.39010 Boehringer Ingelheim Investigational Site, Milano, Italy
1160.63.39020 Boehringer Ingelheim Investigational Site, Milano, Italy
1160.63.39022 Boehringer Ingelheim Investigational Site, Napoli, Italy
1160.63.39001 Boehringer Ingelheim Investigational Site, Palermo, Italy
1160.63.39007 Boehringer Ingelheim Investigational Site, Pisa, Italy
1160.63.39012 Boehringer Ingelheim Investigational Site, Rimini, Italy
1160.63.39017 Boehringer Ingelheim Investigational Site, Roma, Italy
1160.63.39014 Boehringer Ingelheim Investigational Site, Treviso, Italy
1160.63.39002 Boehringer Ingelheim Investigational Site, Udine, Italy
1160.63.39016 Boehringer Ingelheim Investigational Site, Vittorio veneto (TV), Italy
1160.63.82010 Boehringer Ingelheim Investigational Site, Gwangju-si, Korea, Republic of
1160.63.82003 Boehringer Ingelheim Investigational Site, Incheon, Korea, Republic of
1160.63.82005 Boehringer Ingelheim Investigational Site, Kyeonggi-do, Korea, Republic of
1160.63.82001 Boehringer Ingelheim Investigational Site, Kyunggi-do, Korea, Republic of
1160.63.82004 Boehringer Ingelheim Investigational Site, Seoul, Korea, Republic of
1160.63.82006 Boehringer Ingelheim Investigational Site, Seoul, Korea, Republic of
1160.63.82008 Boehringer Ingelheim Investigational Site, Seoul, Korea, Republic of
1160.63.82011 Boehringer Ingelheim Investigational Site, Seoul, Korea, Republic of
1160.63.82007 Boehringer Ingelheim Investigational Site, Suwon, Korea, Republic of
1160.63.37101 Boehringer Ingelheim Investigational Site, Daugavpils, Latvia
1160.63.37102 Boehringer Ingelheim Investigational Site, Riga, Latvia
1160.63.37002 Boehringer Ingelheim Investigational Site, Kaunas, Lithuania
1160.63.37001 Boehringer Ingelheim Investigational Site, Vilnius, Lithuania
1160.63.31010 Boehringer Ingelheim Investigational Site, Assen, Netherlands
1160.63.31006 Boehringer Ingelheim Investigational Site, Breda, Netherlands
1160.63.31007 Boehringer Ingelheim Investigational Site, Den Haag, Netherlands
1160.63.31011 Boehringer Ingelheim Investigational Site, Den Helder, Netherlands
1160.63.31012 Boehringer Ingelheim Investigational Site, Dirksland, Netherlands
1160.63.31003 Boehringer Ingelheim Investigational Site, Eindhoven, Netherlands
1160.63.31001 Boehringer Ingelheim Investigational Site, Groningen, Netherlands
1160.63.31009 Boehringer Ingelheim Investigational Site, Heerlen, Netherlands
1160.63.31008 Boehringer Ingelheim Investigational Site, Oss, Netherlands
1160.63.64002 Boehringer Ingelheim Investigational Site, Christchurch, New Zealand
1160.63.48010 Boehringer Ingelheim Investigational Site, Kielce, Poland
1160.63.48003 Boehringer Ingelheim Investigational Site, Poznan, Poland
1160.63.48001 Boehringer Ingelheim Investigational Site, Warsaw, Poland
1160.63.48002 Boehringer Ingelheim Investigational Site, Warsaw, Poland
1160.63.48004 Boehringer Ingelheim Investigational Site, Warsaw, Poland
1160.63.48005 Boehringer Ingelheim Investigational Site, Warsaw, Poland
1160.63.48006 Boehringer Ingelheim Investigational Site, Warsaw, Poland
1160.63.48007 Boehringer Ingelheim Investigational Site, Warsaw, Poland
1160.63.48008 Boehringer Ingelheim Investigational Site, Warsaw, Poland
1160.63.07007 Boehringer Ingelheim Investigational Site, Ekaterinburg, Russian Federation
1160.63.07004 Boehringer Ingelheim Investigational Site, Kursk, Russian Federation
1160.63.07014 Boehringer Ingelheim Investigational Site, Ufa, Russian Federation
1160.63.07005 Boehringer Ingelheim Investigational Site, Yaroslavl, Russian Federation
1160.63.07006 Boehringer Ingelheim Investigational Site, Yaroslavl, Russian Federation
1160.63.65001 Boehringer Ingelheim Investigational Site, Singapore, Singapore
1160.63.27003 Boehringer Ingelheim Investigational Site, Cape Town, South Africa
1160.63.27007 Boehringer Ingelheim Investigational Site, Centurion, South Africa
1160.63.27009 Boehringer Ingelheim Investigational Site, Krugersdorp, South Africa
1160.63.27001 Boehringer Ingelheim Investigational Site, Somerset West, South Africa
1160.63.46001 Boehringer Ingelheim Investigational Site, Göteborg, Sweden
1160.63.46006 Boehringer Ingelheim Investigational Site, Göteborg, Sweden
1160.63.46002 Boehringer Ingelheim Investigational Site, Lund, Sweden
1160.63.46004 Boehringer Ingelheim Investigational Site, Mölndal, Sweden
1160.63.46007 Boehringer Ingelheim Investigational Site, Skövde, Sweden
1160.63.46005 Boehringer Ingelheim Investigational Site, Stockholm, Sweden
1160.63.46003 Boehringer Ingelheim Investigational Site, Värnamo, Sweden
1160.63.41012 Boehringer Ingelheim Investigational Site, Basel, Switzerland
1160.63.41011 Boehringer Ingelheim Investigational Site, Bruderholz, Switzerland
1160.63.41003 Boehringer Ingelheim Investigational Site, Cham, Switzerland
1160.63.41001 Boehringer Ingelheim Investigational Site, Glarus, Switzerland
1160.63.41016 Boehringer Ingelheim Investigational Site, Luzern 16, Switzerland
1160.63.41014 Boehringer Ingelheim Investigational Site, Luzern, Switzerland
1160.63.41005 Boehringer Ingelheim Investigational Site, Schiers, Switzerland
1160.63.41009 Boehringer Ingelheim Investigational Site, Thun, Switzerland
1160.63.41022 Boehringer Ingelheim Investigational Site, Wetzikon, Switzerland
1160.63.41008 Boehringer Ingelheim Investigational Site, Zug, Switzerland
1160.63.41006 Boehringer Ingelheim Investigational Site, Zurich, Switzerland
1160.63.66002 Boehringer Ingelheim Investigational Site, Bangkok, Thailand
1160.63.66003 Boehringer Ingelheim Investigational Site, Bangkok, Thailand
1160.63.66004 Boehringer Ingelheim Investigational Site, Bangkok, Thailand
1160.63.66001 Boehringer Ingelheim Investigational Site, Chiang Mai, Thailand
1160.63.01025 Boehringer Ingelheim Investigational Site, Birmingham, Alabama, United States
1160.63.01023 Boehringer Ingelheim Investigational Site, Huntsville, Alabama, United States
1160.63.02013 Boehringer Ingelheim Investigational Site, Edmonton, Alberta, Canada
1160.63.01002 Boehringer Ingelheim Investigational Site, Laguna Hills, California, United States
1160.63.01014 Boehringer Ingelheim Investigational Site, Colorado Springs, Colorado, United States
1160.63.01003 Boehringer Ingelheim Investigational Site, Jacksonville, Florida, United States
1160.63.01030 Boehringer Ingelheim Investigational Site, Key West, Florida, United States
1160.63.01022 Boehringer Ingelheim Investigational Site, Lafayette, Louisiana, United States
1160.63.01044 Boehringer Ingelheim Investigational Site, New Iberia, Louisiana, United States
1160.63.01017 Boehringer Ingelheim Investigational Site, Biddeford, Maine, United States
1160.63.01004 Boehringer Ingelheim Investigational Site, Salisbury, Maryland, United States
1160.63.01016 Boehringer Ingelheim Investigational Site, Worcester, Massachusetts, United States
1160.63.01037 Boehringer Ingelheim Investigational Site, St. Louis, Missouri, United States
1160.63.01019 Boehringer Ingelheim Investigational Site, Missoula, Montana, United States
1160.63.02004 Boehringer Ingelheim Investigational Site, Saint John, New Brunswick, Canada
1160.63.01032 Boehringer Ingelheim Investigational Site, Columbus, Ohio, United States
1160.63.02005 Boehringer Ingelheim Investigational Site, Hamilton, Ontario, Canada
1160.63.01001 Boehringer Ingelheim Investigational Site, Uniontown, Pennsylvania, United States
1160.63.01024 Boehringer Ingelheim Investigational Site, Uniontown, Pennsylvania, United States
1160.63.61002 Boehringer Ingelheim Investigational Site, Greenslopes, Queensland, Australia
1160.63.61003 Boehringer Ingelheim Investigational Site, Elizabeth Vale, South Australia, Australia
1160.63.01005 Boehringer Ingelheim Investigational Site, Charleston, South Carolina, United States
1160.63.01020 Boehringer Ingelheim Investigational Site, Spartanburg, South Carolina, United States
1160.63.01011 Boehringer Ingelheim Investigational Site, Salt Lake City, Utah, United States
1160.63.61001 Boehringer Ingelheim Investigational Site, Clayton, Victoria, Australia
1160.63.01007 Boehringer Ingelheim Investigational Site, Richmond, Virginia, United States
1160.63.01035 Boehringer Ingelheim Investigational Site, Bellevue, Washington, United States
1160.63.61004 Boehringer Ingelheim Investigational Site, Nedlands, Western Australia, Australia